Skip to content
2000
Volume 25, Issue 13
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Metabolic dysfunction-associated steatohepatitis (MASH) is a major cause of a worldwide clinical and financial burden. Despite the tremendous efforts for untangling the molecular mechanisms, there is still a need for defining specific therapeutic targets. In this study, the author will focus on the role of erythrocyte death and hepatic erythrophagocytosis in MASH. Evidence indicates that erythrolysis prior to erythrophagocytosis protects against the development of MASH, while phagocytosis of intact erythrocytes culminates in hepatic inflammation. Furthermore, understanding the balance between erythrolysis and intact erythrocyte engulfment could lead to the development of new strategies for the treatment of MASH.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303362972241121062515
2024-10-09
2025-12-13

  • From This Site

    /content/journals/emiddt/10.2174/0118715303362972241121062515
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/emiddt/25/13/EMIDDT-25-13-01.html?itemId=/content/journals/emiddt/10.2174/0118715303362972241121062515&mimeType=html&fmt=ahah

References

  1. YounossiZ.M. KoenigA.B. AbdelatifD. FazelY. HenryL. WymerM. Global epidemiology of nonalcoholic fatty liver disease-Meta‐analytic assessment of prevalence, incidence, and outcomes.Hepatology2016641738410.1002/hep.2843126707365
     [Google Scholar]
  2. YounossiZ.M. MarchesiniG. Pinto-CortezH. PettaS. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation.Transplantation20191031222710.1097/TP.000000000000248430335697
     [Google Scholar]
  3. YounossiZ.M. TampiR.P. RacilaA. QiuY. BurnsL. YounossiI. NaderF. Economic and clinical burden of nonalcoholic steatohepatitis in patients with type 2 diabetes in the U.S.Diabetes Care202043228328910.2337/dc19‑111331658974
     [Google Scholar]
  4. HateleyC. OlonaA. HallidayL. EdinM.L. KoJ.H. ForlanoR. TerraX. LihF.B. Beltrán-DebónR. ManousouP. PurkayasthaS. MoorthyK. ThurszM.R. ZhangG. GoldinR.D. ZeldinD.C. PetrettoE. BehmoarasJ. Multi-tissue profiling of oxylipins reveal a conserved up-regulation of epoxide:diol ratio that associates with white adipose tissue inflammation and liver steatosis in obesity.EBioMedicine202410310512710.1016/j.ebiom.2024.10512738677183
     [Google Scholar]
  5. PirolaC.J. SalatinoA. Fernández GianottiT. CastañoG.O. GaraycoecheaM. SookoianS. Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease.EBioMedicine202410110499610.1016/j.ebiom.2024.10499638320344
     [Google Scholar]
  6. NoureddinM. SanyalA.J. Pathogenesis of NASH: The impact of multiple pathways.Curr. Hepatol. Rep.201817435036010.1007/s11901‑018‑0425‑731380156
     [Google Scholar]
  7. PapadopoulosC. TentesI. PapazoglouD. AnagnostopoulosK. Lysophospholipid metabolism and signalling in non-alcoholic fatty liver disease.Folia Med. (Plovdiv)202264171210.3897/folmed.64.e5929735851901
     [Google Scholar]
  8. PapadopoulosC. TentesI. AnagnostopoulosK. Lipotoxicity disrupts erythrocyte function: A perspective.Cardiovasc. Hematol. Disord. Drug Targets2021212919410.2174/1871529X2166621071912572834825642
     [Google Scholar]
  9. PapadopoulosC. Erythrocyte glucotoxicity results in vascular inflammation.Endocr. Metab. Immune Disord. Drug Targets202222990190310.2174/187153032266622043001333435507805
     [Google Scholar]
  10. TheurlI. HilgendorfI. NairzM. TymoszukP. HaschkaD. AsshoffM. HeS. GerhardtL.M.S. HolderriedT.A.W. SeifertM. SopperS. FennA.M. AnzaiA. RattikS. McAlpineC. TheurlM. WieghoferP. IwamotoY. WeberG.F. HarderN.K. ChoustermanB.G. ArvedsonT.L. McKeeM. WangF. LutzO.M.D. RezoagliE. BabittJ.L. BerraL. PrinzM. NahrendorfM. WeissG. WeisslederR. LinH.Y. SwirskiF.K. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver.Nat. Med.201622894595110.1038/nm.414627428900
     [Google Scholar]
  11. QiJ. KimJ.W. ZhouZ. LimC.W. KimB. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation–mediated cell death in mice.Am. J. Pathol.20201901688110.1016/j.ajpath.2019.09.01131610178
     [Google Scholar]
  12. OtogawaK. KinoshitaK. FujiiH. SakabeM. ShigaR. NakataniK. IkedaK. NakajimaY. IkuraY. UedaM. ArakawaT. HatoF. KawadaN. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis.Am. J. Pathol.2007170396798010.2353/ajpath.2007.06044117322381
     [Google Scholar]
  13. ParkJ.B. KoK. BaekY.H. KwonW.Y. SuhS. HanS.H. KimY.H. KimH.Y. YooY.H. Pharmacological prevention of ectopic erythrophagocytosis by cilostazol mitigates ferroptosis in NASH.Int. J. Mol. Sci.202324161286210.3390/ijms24161286237629045
     [Google Scholar]
  14. PuylaertP. RothL. Van PraetM. PintelonI. DumitrascuC. van NuijsA. KlejborowskaG. GunsP.J. BergheT.V. AugustynsK. De MeyerG.R.Y. MartinetW. Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques.Angiogenesis202326450552210.1007/s10456‑023‑09877‑637120604
     [Google Scholar]
  15. PfefferléM. IngogliaG. SchaerC.A. YalamanogluA. BuzziR. DubachI.L. TanG. López-CanoE.Y. SchulthessN. HansenK. HumarR. SchaerD.J. VallelianF. Hemolysis transforms liver macrophages into antiinflammatory erythrophagocytes.J. Clin. Invest.2020130105576559010.1172/JCI13728232663195
     [Google Scholar]
  16. PapadopoulosC. SpouritaE. MimidisK. KoliosG. TentesL. AnagnostopoulosK. Nonalcoholic fatty liver disease patients exhibit reduced CD47 and increased sphingosine, cholesterol, and monocyte chemoattractant protein-1 levels in the erythrocyte membranes.Metab. Syndr. Relat. Disord.202220737738310.1089/met.2022.000635532955
     [Google Scholar]
  17. PapadopoulosC. MimidisK. TentesI. TenteT. AnagnostopoulosK. Validation and application of a protocol for the extraction and quantitative analysis of sphingomyelin in erythrocyte membranes of patients with non-alcoholic fatty liver disease.J. Planar Chromatogr. Mod. TLC202134541141810.1007/s00764‑021‑00127‑3
     [Google Scholar]
  18. ChoiY.K. KimY.M. Beneficial and detrimental roles of heme oxygenase-1 in the neurovascular system.Int. J. Mol. Sci.20222313704110.3390/ijms2313704135806040
     [Google Scholar]
  19. SantarinoI.B. VieiraO.V. Maturation of phagosomes containing different erythrophagocytic particles in primary macrophages.FEBS Open Bio2017791281129010.1002/2211‑5463.1226228904858
     [Google Scholar]
  20. NguyenJ.A. YatesR.M. Better together: Current insights into phagosome-lysosome fusion.Front. Immunol.20211263607810.3389/fimmu.2021.63607833717183
     [Google Scholar]
  21. CatalaA. Metabolic reprogramming of mouse bone marrow derived macrophages following erythrophagocytosis.Front Physiol.20201139610.3389/fphys.2020.00396
     [Google Scholar]
  22. ZhangK.R. JankowskiC.S.R. MarshallR. NairR. Más GómezN. AlnemriA. LiuY. ErlerE. FerranteJ. SongY. BellB.A. BaumannB.H. SterlingJ. AndersonB. FosheS. RoofJ. FazeliniaH. SpruceL.A. ChuangJ.Z. SungC.H. DhingraA. Boesze-BattagliaK. ChavaliV.R.M. RabinowitzJ.D. MitchellC.H. DunaiefJ.L. Oxidative stress induces lysosomal membrane permeabilization and ceramide accumulation in retinal pigment epithelial cells.Dis. Model. Mech.2023167dmm05006610.1242/dmm.05006637401371
     [Google Scholar]
  23. Rayego-MateosS. Morgado-PascualJ.L. García-CaballeroC. LazaroI. Sala-VilaA. Opazo-RiosL. Mas-FontaoS. EgidoJ. Ruiz-OrtegaM. MorenoJ.A. Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade.J. Pathol.2023261216918310.1002/path.616137555366
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303362972241121062515
Loading

  • Article Type:     Review Article
Keyword(s): efferocytosis; erythrocytes; erythrophagocytosis; Ferroptosis; immunometabolism; MASH

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test